Captor Therapeutics S.A.
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
CTX | WAR
Overview
Corporate Details
- ISIN(s):
- PLCPTRT00014 (+1 more)
- LEI:
- 259400JHH1S2I2S4O735
- Country:
- Poland
- Address:
- Wrocław Duńska 11, 54-427 Wrocław
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Captor Therapeutics S.A. is a clinical-stage biopharmaceutical company specializing in the discovery and development of novel therapeutics using Targeted Protein Degradation (TPD) technology. The company focuses on creating breakthrough, first-in-class treatments for high unmet medical needs, particularly in oncology and autoimmune diseases. Its core is the proprietary Optigrade™ drug discovery platform, which leverages multidisciplinary expertise in protein engineering, structural biology, and molecular modelling. This integrated approach enables the company to address previously "undruggable" molecular targets, accelerating the development of drug candidates with the potential to significantly impact patient outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-25 19:30 |
Director's Dealing
Załącznik do raportu
|
Polish | 715.9 KB | ||
| 2025-09-25 19:30 |
Director's Dealing
Informacja o transakcji na akcjach Spółki uzyskana w trybie art. 19 MAR - Conte…
|
Polish | 563 bytes | ||
| 2025-09-25 15:43 |
Director's Dealing
Załącznik do raportu
|
English | 129.5 KB | ||
| 2025-09-25 15:43 |
Director's Dealing
Informacja o transakcji na akcjach Spółki uzyskana w trybie art. 19 MAR - Conte…
|
Polish | 554 bytes | ||
| 2025-09-25 13:11 |
Director's Dealing
Załącznik do raportu
|
Polish | 4.3 KB | ||
| 2025-09-25 13:11 |
Director's Dealing
Informacja o transakcji na akcjach Spółki uzyskana w trybie art. 19 MAR - Conte…
|
Polish | 557 bytes | ||
| 2025-09-25 13:03 |
Director's Dealing
Załącznik do raportu
|
Polish | 4.6 KB | ||
| 2025-09-25 13:03 |
Director's Dealing
Informacja o transakcji na akcjach Spółki uzyskana w trybie art. 19 MAR - Conte…
|
Polish | 698 bytes | ||
| 2025-09-24 20:38 |
Pre-Annual General Meeting Information
informacja o ogólnej liczbie głosów
|
Polish | 129.7 KB | ||
| 2025-09-24 20:38 |
Pre-Annual General Meeting Information
wzór instrukcji wykonywania prawa głosu przez pełnomocnika
|
Polish | 255.2 KB | ||
| 2025-09-24 20:38 |
Proxy Solicitation & Information Statement
wzór pełnomocnictwa
|
Polish | 84.9 KB | ||
| 2025-09-24 20:38 |
Share Issue/Capital Change
opinia Zarządu
|
Polish | 180.3 KB | ||
| 2025-09-24 20:38 |
Pre-Annual General Meeting Information
projekty uchwał
|
Polish | 346.4 KB | ||
| 2025-09-24 20:38 |
Pre-Annual General Meeting Information
ogłoszenie
|
Polish | 277.1 KB | ||
| 2025-09-24 20:38 |
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu Nadzwyczajnego Walnego Zgromadzenia oraz dokumenty związa…
|
Polish | 1.3 KB |
Automate Your Workflow. Get a real-time feed of all Captor Therapeutics S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Captor Therapeutics S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
